Trials / Not Yet Recruiting
Not Yet RecruitingNCT07142057
An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on Lung Cancer Patients
An Observational Study on the Impact of the 23-valent Pneumonia Vaccine on the Incidence of Pulmonary Infection and Survival in Lung Cancer Patients
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the impact of the 23-valent pneumonia vaccine on the incidence of pulmonary infection and survival in lung cancer patients, and to explore its preventive effect and safety in the lung cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | 23-valent pneumococcal vaccine | Receive the 23-valent pneumococcal vaccine; Do not receive the 23-valent pneumococcal vaccine |
Timeline
- Start date
- 2025-09-01
- Primary completion
- 2027-09-01
- Completion
- 2030-09-01
- First posted
- 2025-08-26
- Last updated
- 2025-08-26
Source: ClinicalTrials.gov record NCT07142057. Inclusion in this directory is not an endorsement.